Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer entities : Biocept, inc. save search
Global Biopsy Devices Market Projected to Reach $11.86 Billion by 2027, Fueled by Rising Cancer Incidence and Advanced Diagnostic Procedures
Published: 2023-11-10 (Crawled : 01:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -3.09%
H: 0.0%
C: 0.0%
SYK | $325.43 -0.62% 0.0% 1.8M
|
Health Technology
|
| O: 0.3%
H: 1.31%
C: 0.72%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: 0.49%
H: 0.57%
C: 0.35%
CNMD | $72.64 2.2% 0.0% 500K
|
Health Technology
|
| O: 0.21%
H: 1.91%
C: 1.65%
CAH | $108.19 2.07% 0.0% 1.5M
|
Distribution Services
|
| O: 0.26%
H: 1.46%
C: 1.01%
BSX | $67.33 -0.13% -0.31% 7M
|
Health Technology
|
| O: 0.43%
H: 0.41%
C: -0.17%
BIO | $279.73 -0.46% 0.0% 290K
|
Health Technology
|
| O: -0.27%
H: 0.44%
C: -0.63%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: 0.68%
H: 0.8%
C: 0.35%
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: -12.11%
H: 4.83%
C: 4.63%
CNMD | $72.64 2.2% -1.98% 500K
|
Health Technology
|
| O: 0.21%
H: 1.91%
C: 1.65%
diagnostic reach cancer global market
Global Rare Biomarkers Specimen Collection and Stabilization Market Set to Reach $84.18 Billion by 2030, Driven by Expanding Applications in Liquid Biopsy and Cancer Research
Published: 2023-11-02 (Crawled : 09:00) - prnewswire.com
BIO | $279.73 -0.46% 0.0% 290K
|
Health Technology
|
| O: 1.37%
H: 1.2%
C: -0.04%
TECH | $62.12 -0.15% -0.14% 910K
|
Health Technology
|
| O: 1.78%
H: 4.05%
C: 3.05%
rare reach cancer research global set biomarkers market
Biocept’s CNSide™ Cerebrospinal Fluid Assay Featured in Two Oral Presentations at the 2023 SNO/ASCO CNS Cancer Conference
Published: 2023-08-14 (Crawled : 12:20) - biospace.com/
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: 3.7%
H: 2.68%
C: -1.79%
conference cancer
World Molecular Diagnostics for Cancer Markets Report 2023: The New Automation, Decentralization and Point Of Care
Published: 2023-02-10 (Crawled : 01:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -0.32%
H: 0.81%
C: 0.76%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: -1.8%
H: 1.83%
C: -4.59%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: 0.18%
H: 0.94%
C: 0.88%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.18%
H: 0.59%
C: -0.09%
MLAB | $101.19 1.58% 1.55% 27K
|
Health Technology
|
| O: -0.73%
H: 2.8%
C: 2.25%
ICLR | $288.32 -1.2% -1.21% 640K
|
Health Technology
|
| O: -0.66%
H: 1.6%
C: -0.18%
CSTL | $19.28 0.42% 0.41% 130K
|
Health Technology
|
| O: -0.8%
H: 1.84%
C: 1.53%
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: 0.0%
H: 1.63%
C: 1.59%
TXG | $27.92 -3.56% -3.69% 2M
|
Health Technology
|
| O: -2.24%
H: 1.83%
C: 0.59%
care report diagnostics molecular cancer
Global Genomic Cancer Panel and Profiling Markets, 2023-2027: An Exploding Market as Physicians Use All the Information they Can Get in the Battle Against Cancer
Published: 2023-02-10 (Crawled : 01:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -0.32%
H: 0.81%
C: 0.76%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: -1.8%
H: 1.83%
C: -4.59%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: 0.18%
H: 0.94%
C: 0.88%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.18%
H: 0.59%
C: -0.09%
MLAB | $101.19 1.58% 1.55% 27K
|
Health Technology
|
| O: -0.73%
H: 2.8%
C: 2.25%
ICLR | $288.32 -1.2% -1.21% 640K
|
Health Technology
|
| O: -0.66%
H: 1.6%
C: -0.18%
CSTL | $19.28 0.42% 0.41% 130K
|
Health Technology
|
| O: -0.8%
H: 1.84%
C: 1.53%
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: 0.0%
H: 1.63%
C: 1.59%
TXG | $27.92 -3.56% -3.69% 2M
|
Health Technology
|
| O: -2.24%
H: 1.83%
C: 0.59%
global genomic cancer market
Market Forecasts for Immuno-Oncology Diagnostics 2023: Sector Represents a Revolution in Cancer Therapy
Published: 2023-01-20 (Crawled : 22:00) - prnewswire.com
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
| Email alert
Add to watchlist
ANPCY | $1.98 338.38% 930
|
Manufacturing
| Email alert
Add to watchlist
BIO | $279.73 -0.46% 0.0% 290K
|
Health Technology
| Email alert
Add to watchlist
TXG | $27.92 -3.56% -3.69% 2M
|
Health Technology
| Email alert
Add to watchlist
NVTA | $0.019 0.0% 22M
|
Health Services
| Email alert
Add to watchlist
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
| Email alert
Add to watchlist
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
| Email alert
Add to watchlist
ANPCF | $0.148 641.22% 5K
|
Health Technology
| Email alert
Add to watchlist
CSTL | $19.28 0.42% 0.41% 130K
|
Health Technology
| Email alert
Add to watchlist
ICLR | $288.32 -1.2% -1.21% 640K
|
Health Technology
| Email alert
Add to watchlist
BIOC | $0.4349 -10.32% 750K
|
Health Services
| Email alert
Add to watchlist
NH | $1.35 -46.64% -1.48% 0
|
Technology Services
| Email alert
Add to watchlist
MLAB | $101.19 1.58% 1.55% 27K
|
Health Technology
| Email alert
Add to watchlist
diagnostics therapy cancer market
Global Immuno-Oncology Diagnostics Market Report 2023-2028: Diagnostic Companies and Instrumentation Suppliers are Jockeying for Position in a New Approach to Conquering Cancer
Published: 2023-01-19 (Crawled : 16:00) - prnewswire.com
ANPCY | $1.98 338.38% 930
|
Manufacturing
|
| O: 5.84%
H: 0.0%
C: 0.0%
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -0.87%
H: 2.11%
C: 1.54%
NVTA | $0.019 0.0% 22M
|
Health Services
|
| O: -1.74%
H: 2.17%
C: -4.54%
BIO | $279.73 -0.46% 0.0% 290K
|
Health Technology
|
| O: -1.15%
H: 1.03%
C: 0.76%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: -0.36%
H: 1.01%
C: 0.52%
CSTL | $19.28 0.42% 0.41% 130K
|
Health Technology
|
| O: -1.07%
H: 1.1%
C: -2.2%
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: -3.0%
H: 3.15%
C: -1.93%
TXG | $27.92 -3.56% -3.69% 2M
|
Health Technology
|
| O: -2.52%
H: 1.84%
C: 1.08%
global companies report diagnostic diagnostics cancer market
Biocept Announces Participation in an Investigator-Initiated Study to Better Understand the Development and Progression of Metastatic Breast Cancer to the Central Nervous System
Published: 2022-11-16 (Crawled : 14:00) - biospace.com/
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: 2.43%
H: 0.58%
C: -4.64%
system breast cancer study metastatic breast cancer
Global Liquid Biopsy Market Report 2022: Increased Awareness Regarding Cancer Boosts 13.77% Annual Growth
Published: 2022-11-08 (Crawled : 21:00) - prnewswire.com
BIO | $279.73 -0.46% 0.0% 290K
|
Health Technology
|
| O: -0.44%
H: 6.91%
C: 6.14%
NTRA S | $85.275 -2.3% -2.35% 2.5M
|
Health Services
|
| O: 3.06%
H: 0.43%
C: -15.25%
MYGN F | $18.515 0.03% 0.03% 490K
|
Health Technology
|
| O: -0.78%
H: 5.43%
C: 3.08%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: -1.08%
H: 1.4%
C: 0.07%
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: -1.24%
H: 3.8%
C: -6.33%
global report cancer growth market
Breast Cancer Liquid Biopsy Testing Devices Market Size to Grow by USD 730.4 Mn, CTCs and Circulating Nucleic Acids to be Largest Revenue-generating Type Segment - Technavio
Published: 2022-11-08 (Crawled : 19:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -0.14%
H: 0.91%
C: -1.38%
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: -1.24%
H: 3.8%
C: -6.33%
breast cancer market
Biocept to Host KOL Webinar Today to Discuss its Proprietary CNSide™ Assay to Detect and Quantify Cancer that Metastasized to the Central Nervous System
Published: 2022-10-14 (Crawled : 15:20) - biospace.com/
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: 0.0%
H: 0.0%
C: -1.88%
system cancer today
Biocept to Host Key Opinion Leader Webinar on October 14 to Discuss its Proprietary CNSide™ Assay to Detect and Quantify Cancer that Metastasized to the Central Nervous System
Published: 2022-10-06 (Crawled : 20:00) - biospace.com/
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: 0.26%
H: 1.66%
C: -2.27%
system cancer
Brain Cancer Diagnostics Market to Reach $7.37 Billion by 2028
Published: 2022-09-09 (Crawled : 13:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 3.54%
H: 0.0%
C: 0.0%
PHG | $19.98 0.0% 540K
|
Health Technology
|
| O: 2.57%
H: 0.69%
C: -0.17%
NVDA | $762.01 -10.0% -10.37% 87M
|
Electronic Technology
|
| O: 1.19%
H: 2.24%
C: 1.62%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: 0.33%
H: 1.42%
C: 1.13%
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: 5.73%
H: 0.0%
C: -7.3%
diagnostics cancer market train
Rising Prevalence of Cancer Driving the Market Growth of Liquid Biopsy Market to reach $19.35 Billion by 2028: Grand View Research, Inc.
Published: 2022-08-16 (Crawled : 14:20) - prnewswire.com
MYGN F | $18.515 0.03% 0.03% 490K
|
Health Technology
|
| O: -0.61%
H: 0.11%
C: -2.89%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: -1.05%
H: 0.3%
C: -1.95%
GH M | $16.08 -3.54% -3.67% 1.9M
|
Health Services
|
| O: -0.91%
H: 0.0%
C: -2.51%
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: 0.0%
H: 0.0%
C: -12.5%
cancer growth market
Biocept Presentation at Molecular Medicine Tri-Con Meeting Highlights Potential of CNSide™ Assay to Support Development of Targeted Therapies for Metastatic Brain Cancer
Published: 2022-02-22 (Crawled : 23:00) - biospace.com/
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: -2.92%
H: 0.43%
C: -3.43%
brain cancer presentation potential molecular cancer train
Analysis of the Worldwide Liquid Biopsy Market to 2028: Rising Preference For Minimally Invasive Form Of Cancer Diagnostics
Published: 2021-12-24 (Crawled : 21:00) - prnewswire.com
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
| Email alert
Add to watchlist
BIOC | $0.4349 -10.32% 750K
|
Health Services
| Email alert
Add to watchlist
ANPCF | $0.148 641.22% 5K
|
Health Technology
| Email alert
Add to watchlist
MYGN F | $18.515 0.03% 0.03% 490K
|
Health Technology
| Email alert
Add to watchlist
ANPCY | $1.98 338.38% 930
|
Manufacturing
| Email alert
Add to watchlist
GH M | $16.08 -3.54% -3.67% 1.9M
|
Health Services
| Email alert
Add to watchlist
diagnostic diagnostics cancer
Biocept’s CNSide Cerebrospinal Fluid Assay Identifies Actionable HER2 Mutations in Patients with Breast Cancer that has Metastasized to the Brain
Published: 2021-12-09 (Crawled : 14:30) - biospace.com/
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: -1.9%
H: 0.0%
C: 0.0%
cancer breast cancer her2- train her2
Quest Diagnostics Now Offers Biocept's Liquid Biopsy Test for Lung Cancer, Expanding its Menu of Advanced Cancer Diagnostics
Published: 2021-12-01 (Crawled : 15:00) - biospace.com/
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
|
| O: -3.77%
H: 3.8%
C: 1.5%
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: 2.53%
H: 8.53%
C: -4.44%
diagnostic diagnostics lung cancer test cancer
Biocept’s CNSide Cerebrospinal Fluid Assay Aids in Monitoring Treatment Response and Detects Actionable Biomarkers in Patients with Metastatic Breast Cancer
Published: 2021-11-18 (Crawled : 21:00) - biospace.com/
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: 1.06%
H: 0.48%
C: -4.71%
treatment cancer breast cancer response biomarkers metastatic breast cancer
Study Shows Biocept’s Switch-Blocker Technology Enhances Performance of Conventional PCR-Based Liquid Biopsy Assays in Detecting Rare Cancer Mutations
Published: 2021-11-09 (Crawled : 14:00) - biospace.com/
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: -1.28%
H: 1.3%
C: 1.04%
cancer technology rare
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.